National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

STATUTORY RULES.

1954. No. 128.

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953.*

I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953.

Dated this fifteenth day of December, 1954.

W.J. Slim

Governor-General.

By His Excellency's Command,

Minister of State for Health.

Amendments of the National Health (Pharmaceutical

Benefits) Regulations. 

Commencement.

1. These Regulations shall come into operation on the first day of January, 1955.

Certain requirements to be met after cancellation, &c., of approval.

2. Regulation 7 of the National Health (Pharmaceutical Benefits) Regulations is amended by omitting the word "approved" (second occurring).

General pharmaceutical benefits.

3. Regulation 8 of the National Health (Pharmaceutical Benefits) Regulations is amended by omitting sub-regulation (4.).

* Notified in the Commonwealth Gazette on , 1954

  Statutory Rules 1954, No. 54, as amended by Statutory Rules 1954, Nos. 77, 78, 93 and 95.

5223.—Price 3d. 9/2.12.1954.

Writing of prescriptions.

4. Regulation 19 of the National Health (Pharmaceutical Benefits) Regulations is amended by inserting in paragraph (g) of sub-regulation (1.), after the words "Second Schedule", the words "other than a prescription for the supply to a pensioner of a drug referred to in sub-regulation (3.) of regulation 8 of these Regulations".

Supply of pharmaceutical benefits on prescriptions.

5. Regulation 23 of the National Health (Pharmaceutical Benefits) Regulations is amended—

(a) by omitting from sub-regulation (1.) the words ", an approved medical practitioner or an approved hospital authority (being the proprietor of a private hospital)" and inserting in their stead the words "or an approved medical practitioner"; and

(b) by omitting from sub-regulation (2.) the words ",an approved hospital authority".

Supply of pharmaceutical benefit before surrender of written prescription.

6. Regulation 24 of the National Health (Pharmaceutical Benefits) Regulations is amended—

(a) by omitting from sub-regulation (1.) the words "or an approved hospital authority";

(b) by omitting from that sub-regulation the words "or approved hospital authority";

(c) by omitting from sub-regulations (2.) and (3.) the words "or approved hospital authority" (wherever occurring); and

(d) by omitting sub-regulation (4.).

Supply of pharmaceutical benefit on first presentation of prescription.

7. Regulation 25 of the National Health (Pharmaceutical Benefits) Regulations is amended by omitting the words ",approved medical practitioner or approved hospital authority (being the proprietor of a private hospital)" and inserting in their stead the words "or an approved medical practitioner".

Supply of brand of general pharmaceutical benefit specified in a prescription.

8. Regulation 29 of the National Health (Pharmaceutical Benefits) Regulations is amended by omitting the words ",approved hospital authority" (wherever occurring).

Retention of prescriptions, &.c.

9. Regulation 35 of the National Health (Pharmaceutical Benefits) Regulations is amended by omitting the words ",approved medical practitioner or approved hospital authority (being the proprietor of a private hospital) who or which supplies pharmaceutical benefits shall retain in his or its" and inserting in their stead the words "or an approved medical practitioner who supplies pharmaceutical benefits shall retain in his".

First Schedule.

10. The First Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended—

(a) by omitting item 17 and inserting in its stead the following item:—

“17	Bismuth Salicylate, Oily Injection of	..........................................................	1 cc. amp...........................................	12	..
..........................................................	10 cc. amp......................................... .	6	..
..........................................................	25 cc. bottle ....................................... ..	1	..
..........................................................	60 cc. bottle .......................................	1	..
..........................................................	2 fl. oz. bottle ....................................	1	..";

(b) by omitting item 26 and inserting in its stead the following item:—

"26	Chiniofon ........................................	0.25 G. ..............................................	pill ....................................................	25	1
0.25 G. ..............................................	tablet .................................................	25	1";

(c) by omitting item 38 and inserting in its stead the following item:—

"38	Digifortis.........................................	½gr. ..................................................	tablet .................................................	100	1
1 gr	tablet .................................................	100	1";

(d) by omitting item 40 and inserting in its stead the following item:—

"40	Digitoxin..........................................	0.1 mg. .............................................	tablet .................................................	100	1
0.2 mg...............................................	tablet .................................................	100	1
0.25 mg. ...........................................	tablet .................................................	100	1"

(e) by omitting item 72 and inserting in its stead the following item:—

"72	Glyceryl Trinitrate ......................	1/100 gr. ............................................	hypo. tab. ..........................................	100	1
1/200 gr.............................................	tablet .................................................	100	1
1/150 gr.............................................	tablet .................................................	100	1
1/130 gr.............................................	tablet .................................................	100	1
1/100 gr.............................................	tablet .................................................	100	1
1/65 gr...............................................	tablet .................................................	100	1
1/50 gr...............................................	tablet .................................................	100	1";

(f) by omitting item 82 and inserting in its stead the following item:—

"82	Hyoscine Hydrobromide................	1/150 gr. ............................................	amp. ..................................................	6	..
1/100 gr.............................................	amp. ..................................................	6	..
1/75 gr...............................................	amp. ..................................................	6	1
1/200 gr.............................................	hypo. Tab...........................................	100	1
1/150 gr.............................................	hypo. Tab...........................................	100	1
1/100 gr.............................................	hypo. tab. ..........................................	100	1
1/100 gr. per cc..................................	10 cc. vial ..........................................	1	..";

(g) by omitting item 97;

(h) by omitting item 119 and inserting in its stead the following item:—

"119 Pamaquin ........................................ 0.01 G. .............................................. tablet ................................................. 45 ..";

(i) by omitting item 135 and inserting in its stead the following item:—

"135	Phemitone ........................................	1/2 gr. .................................................	tablet .................................................	200	1
1 gr. ...................................................	tablet .................................................	200	1
3 gr. ...................................................	tablet .................................................	200	1";

(j) by omitting item 139 and inserting in its stead the following item:—

"139	Phenytoin Sodium ...........................	0.03 G................................................	capsule ..............................................	200	1
0.1 G .................................................	capsule ..............................................	200	1
0.1 G..................................................	tablet .................................................	200	1";

(k) by omitting item 161 and inserting in its stead the following item:—

"161	Sodium Chloride Physiological	..........................................................	2 cc.. amp. .........................................	6	1
Solution for Injection	..........................................................	5 cc. amp. ..........................................	6	1
..........................................................	10 cc. amp..........................................	6	1
..........................................................	10 cc.. vial .........................................	2	1"

(l) by omitting item 181 and inserting in its stead the following item:—

"181	Tetanus Antitoxin .........................	500 I.U. .............................................	amp. ..................................................	6	1
1,000 I.U. ..........................................	amp. ..................................................	6	1
1,500 I.U............................................	amp. ..................................................	6	1
10,000 I.U. ........................................	amp. ..................................................	6	1"

(m) by omitting item 189 and inserting in its stead the following item:—

"189 Triethanolamine Trinitrate.......... 1 mg. ............................................ tablet ............................................ 100 1"; and

(n) by omitting item 195 and inserting in its stead the following item:—

"195	Water for Injection .......................	..........................................................	2 cc. amp...........................................	6	3
..........................................................	5 cc. amp...........................................	6	3
..........................................................	10 cc. amp. ........................................	6	3".

Second Schedule.

11. The Second Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended by omitting item 25 and inserting in its stead the following item:—

"25	Streptomycin Sulphate Solution for Injection...................................	250,000 U. per mil.................................. . per mil. .................................	4 mil. vial.......................................... .. ..	5	3	Any disease or purpose specified in this column in relation to streptomycin".
500,000 U. per mil.................................. r mil. .................................	2 mil. vial. .. .......................................... ..	5	3

 

12. The Third Schedule to the National Health (Pharmaceutical Third Schedule Benefits) Regulations is amended—

(a) by inserting after item 134 the following item:—

"134a | Tabellae Amphetaminae Sulphatis B.P.C.";

(b) by inserting after item 141 the following item:—

"141a | Tabellae Saccharini B.F.C."; and

(c) by inserting after item 143 the following item:—

 "143a | Tabellae Sodii Salicylatis (Enteric Coated)".

Fourth Schedule.

13. The Fourth Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended by inserting after the words and figures—

"Tablets of phenobarbitone sodium ................................................................. 100"

the words and figures—

"Tablets of saccharin ....................................................................................	200
Tablets of theobromine sodium salicylate .......................................................	100".

Printed for the Government of the Commonwealth by A. J. Arthur

at the Government Printing Office, Canberra.